Published on 17 Apr 2024 on Simply Wall St. via Yahoo Finance
Bio-Rad Laboratories (NYSE:BIO shareholders incur further losses as stock declines 14% this week,...
Investing in stocks inevitably means buying into some companies that perform poorly. Long term Bio-Rad Laboratories, Inc. (NYSE:BIO) shareholders know that all too well, since the share price is down considerably over three years. So they might be feeling emotional about the 53% share price collapse, in that time. And the ride hasn't got any smoother in recent times over the last year, with the price 39% lower in that time. And the share price decline continued over the last week, dropping some 14%.
With the stock having lost 14% in the past week, it's worth taking a look at business performance and seeing if there's any red flags.